drugset / Trial / NCT00046241

Prevention of Seasonal Affective Disorder

NCT00046241

Phase 3 Completed 300 enrolled GlaxoSmithKline
RandomizedParallel-groupDouble-blindTreatment

Summary

This is a placebo controlled study evaluating the effectiveness of medication in preventing depressive episodes in subjects with a history of Seasonal Affective Disorder (SAD).

Timeline

Start
2002-09
Primary completion
2003-06
Completion
2003-06

Drugs

EvaluationDrugModalityDoseRoute
Subject Bupropion Small molecule 150 mg
Subject Bupropion Small molecule 300 mg